Found 9 hits of ic50 for monomerid = 50055670 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Protein kinase C beta type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C beta 1 isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
Protein kinase C eta type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C eta isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
Protein kinase C beta type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 69 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C beta 2 isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
Protein kinase C delta type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C delta isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
Protein kinase C gamma type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C gamma isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
Protein kinase C epsilon type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C epsilon isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
Protein kinase C alpha type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 410 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C alpha isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
cAMP-dependent protein kinase catalytic subunit alpha
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration of the compound against recombinant human cAMP-dependent Protein kinase A |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM50055670
(4-(2-Carboxy-6-hydroxy-benzoyl)-3,5-dihydroxy-benz...)Show SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1C2CCN(CC2)C[C@H]1NC(=O)c1ccc(O)cc1 |wU:23.24,wD:31.35,(5.05,-.22,;5.83,-1.57,;7.37,-1.57,;4.73,-2.67,;3.19,-2.67,;2.43,-4.01,;3.2,-5.33,;4.73,-5.33,;3.96,-6.66,;5.5,-4.01,;7.05,-4.01,;7.82,-2.67,;7.82,-5.34,;9.36,-5.33,;10.12,-3.98,;10.13,-6.66,;9.36,-8,;7.82,-8,;7.05,-6.67,;5.95,-7.76,;10.13,-9.34,;9.36,-10.69,;11.68,-9.34,;12.44,-10.37,;11.84,-11.54,;13.1,-11.2,;13.44,-12.46,;14.69,-12.12,;13.59,-13.01,;12.38,-12.68,;14.67,-10.97,;13.71,-10.12,;14.36,-8.72,;15.9,-8.71,;16.67,-10.04,;16.66,-7.37,;18.2,-7.37,;18.97,-6.04,;18.19,-4.7,;18.95,-3.35,;16.63,-4.71,;15.88,-6.06,)| Show InChI InChI=1S/C30H28N2O10/c33-18-6-4-16(5-7-18)28(38)31-20-14-32-10-8-15(9-11-32)27(20)42-30(41)17-12-22(35)25(23(36)13-17)26(37)24-19(29(39)40)2-1-3-21(24)34/h1-7,12-13,15,20,27,33-36H,8-11,14H2,(H,31,38)(H,39,40)/t20-,27-/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
A Division of Eli Lilly & Company
Curated by ChEMBL
| Assay Description Inhibitory concentration against recombinant human Protein kinase C zeta isozyme |
J Med Chem 40: 226-35 (1997)
Article DOI: 10.1021/jm960497g BindingDB Entry DOI: 10.7270/Q2J965HR |
More data for this Ligand-Target Pair | |